|
|
|
|
|
Date |
|
Company |
|
|
|
03/17/11 |
|
Bay State Bedrock Joseph Finn has carved a niche for himself
in Massachusetts ABC Cases, Bankruptcy Insider March 17,
2011 pg. 20 - 21 |
|
12/08/09 |
|
Finn, Warnke & Gayton Announces A New Service For
Biotechnology Firms - A Platform To Sell Intellectual
Property |
|
04/02/09 |
|
Finn, Warnke & Gayton: Non Legal Estate Wrap-up |
|
03/17/09 |
|
Assignment for the Benefit of Creditors: Evaluating the
Option of an ABC? Boston Bar Event Sponsored By Bankrupcty
Law Section |
|
08/22/08 |
|
|
|
02/21/08 |
|
|
|
09/15/99 |
|
CHANGING DIRECTIONS IN MID-STREAM: LESSONS TO BE LEARNED
FROM REPOSITIONING YOUR COMPANY |
|
|
|
|
Finn,
Warnke & Gayton White Papers
|
|
|
|
|
|
|
|
Some Philosophical Notions On
The Problem Of Accounting Principals by Joseph F. Finn, Jr.
1968 |
|
|
|
Problem Studied Using Informal Logic System of Philosophy |
|
|
|
06/19/08 |
|
ActivBiotics Assignee Issues First Distribution of Cash to
Creditors |
|
04/02/08 |
|
ActivBiotics' Intellectual Property Assets, Including Drug
Product Candidates, Sold for $3.5 Million |
|
03/05/08 |
|
ActivBiotics Set to Sell Proprietary Assets, Including Drug
Product Candidates, on March 14, 2008 |
|
02/19/08 |
|
ActivBiotics Outlines a Clinical Path Forward to Examine if
Rifalazil Is Superior to Azithromycin in the Treatment of
Chlamydia STD |
|
01/28/08 |
|
ActivBiotics Completes Sale of Fixed Assets; Expands Due
Diligence Initiative for the Sale of Intellectual Property,
Including Drug Product Candidates |
|
01/15/08 |
|
ActivBiotics Extends Deadline to March 14, 2008 for the Sale
of Proprietary Assets, Including Drug Product Candidates |
|
12/18/07 |
|
ActivBiotics Sells Proprietary Assets, Including Drug
Product Candidates |
|
12/07/07 |
|
ActivBiotics
Inc. Assigns Assets to Joseph F. Finn, Jr. C.P.A. for the
Benefit of Creditors |
| |
|
|
| |
|
|
|
|
|
12/08/11 |
|
AFBC EPIX Pharmaceutical Auction
for S1P1 Assets - all assets sold |
|
11/29/11 |
|
|
|
11/17/11 |
|
AMG 369
Discriminates Against S1P3 Receptor by 296-Fold |
|
11/08/11 |
|
S1P1 Lead
Compounds, Assets Generated by Epix Pharmaceuticals, Inc.
and Amgen, Will Be Offered for Sale at a December 8, 2011
Sealed Bid Sale. Target Rationale for S1P1 Agonists
Explained. |
|
11/01/11 |
|
|
|
10/25/11 |
|
|
|
10/18/11 |
|
|
|
10/12/11 |
|
S1P1 Lead
Compounds, AMG 369 and AMG 277, Will Be Offered for Sale at
a December 8, 2011 Sealed Bid Sale |
|
10/06/11 |
|
S1P1
Program Assets Generated by Epix Pharmaceuticals, Inc. and
Amgen Will Be Offered for Sale at a December 8, 2011 Sealed
Bid Sale |
|
06/22/10 |
|
AFBC EPIX Pharmaceuticals
Auction - all imaging assets sold |
|
05/21/10 |
|
Epix
Pharmaceuticals, Inc. Announces a Change in the May 28, 2010
Auction Sale of Epix Imaging Agents to June 22, 2010 |
|
05/17/10 |
|
Epix
Pharmaceuticals, Inc. Announces Additional Information
Concerning the May 28, 2010 Auction Sale of EP-3600 MRI
Imaging Agent |
|
05/10/10 |
|
EPIX
Pharmaceuticals, Inc. Announces Additional Information
Concerning the May 28, 2010 Auction Sale of EP-2104R MRI
Imaging Agent |
|
05/04/10 |
|
EPIX
Pharmaceuticals, Inc. Announces the May 28, 2010 Auction
Sale of EP-3600 MRI Imaging Agent |
|
04/19/10 |
|
Epix
Pharmaceuticals, Inc. Announces the May 28, 2010 Auction
Sale of EP-2104R MRI Imaging Agent |
|
04/12/10 |
|
Epix
Pharmaceuticals, Inc. Announces the May 28, 2010 Auction
Sale of MS-325 MRI Imaging Agent |
|
04/05/10 |
|
Epix
Pharmaceuticals, Inc. Announces the May 28, 2010 Auction
Sale of Its MRI Imaging Intellectual Properties |
|
10/22/09 |
|
Joseph F.
Finn, Jr., Assignee for the Benefit of Creditors of EPIX
Pharmaceuticals, Inc.,Releases Statement Regarding
Liquidation Process |
|
10/21/09 |
|
AFBC EPIX Pharmaceuticals
auction |
|
10/16/09 |
|
|
|
10/01/09 |
|
Epix
Pharmaceuticals, Inc. Announces a Successful Auction Sale of
Five Drug Program Intellectual Properties on September 30,
2009 |
|
09/30/09 |
|
AFBC EPIX Pharmaceuticals
auction |
|
09/01/09 |
|
EPIX
Pharmaceuticals, Inc. Announces the P2Y2 Gastrointestinal
Early Development Candidate Program Will Be Part of the
Intellectual Property Offered For Sale at the September 30,
2009 Auction |
|
08/25/09 |
|
EPIX
Pharmaceuticals, Inc. Announces the PRX-00023 Therapeutics
CNS Program in Phase 2b/3 Will Be Part of the Intellectual
Property Offered for Sale at the September 30, 2009 Auction |
|
08/18/09 |
|
Epix
Pharmaceuticals, Inc. Announces the PRX-08066 Therapeutics
Program in Phase 2 for Respiratory Indication Will Be Part
of The Intellectual Property Offered for Sale at the
September 30, 2009 Auction |
|
08/13/09 |
|
Epix
Pharmaceuticals, Inc. Announces PRX-07034 Therapeutics - CNS
Phase 2 Will be Part of the Intellectual Property Offered
for Sale at the September 30, 2009 Auction |
|
08/04/09 |
|
EPIX Pharmaceuticals,
Inc. Announces August 25, 2009 for the Auction Sale of
Equipment and September 30, 2009 for the Auction Sale of the
Intellectual Property |
|
07/22/09 |
|
EPIX
Pharmaceuticals Inc., Assigns all Its Assets to Joseph F.
Finn Jr., C.P.A. for the Benefit of Its Creditors |
|
07/20/09 |
|
Epix Pharmaceuticals Assigns
Assets to Joseph F. Finn, Jr. C.P.A. for the Benefit of
Creditors |
|
|
|
|
|
|
|
|
|
|
06/16/08 |
|
Demandware Awarded n2N Commerce’s Assets in Sealed Bid
Auction |
02/19/08
|
|
n2N SOFTWARE TO BE AUCTIONED APRIL 11, 2008
|
|
|
|
|
|
|
|
|
|
|
06/10/11 |
|
Assets Sold |
|
06/01/11 |
|
|
|
05/17/11 |
|
NMT
Medical, Inc. Adds Intellectual Property to Its Sealed Bid
Sale of Friday, June 10, 2011 at Twelve O'Clock Noon |
|
05/10/11 |
|
NMT Medical,
Inc. Sealed Bid Sale of its Intellectual Property to Take
Place Friday, June 10, 2011 at Twelve O'Clock Noon |
|
05/02/11 |
|
|
|
4/20/11 |
|
NMT Medical Assigns Assets to
Joseph F. Finn, Jr. C.P.A. for the Benefit of Creditors
|
|
|
|
|
|
|
|
|
|
|
11/05/10 |
|
AFBC NoblePeak Vision Inc. Auction |
|
10/12/10 |
|
NoblePeak Vision Corp. Offers Patented Technology to
Integrate Germanium Photodetectors with Silicon Circuits at
the November 5, 2010 Sealed Bid Sale |
|
10/04/10 |
|
NoblePeak Vision Corp. Offers Patented Technology to
Integrate Germanium Photodetectors With Silicon Circuits at
the November 5, 2010 Sealed Bid Sale |
|
09/27/10 |
|
NoblePeak Vision Corp. Assigns All Its Assets to Joseph F.
Finn, Jr., C.P.A. for the Benefit of Its Creditors |
|
|
|
|
Prospect Therapeutics Inc.
|
|
06/29/09 |
|
Assets sold |
|
06/22/09 |
|
Prospect Therapeutics Inc.'s GCS-100 Has Focused on
Developing Treatment for Three Blood-Borne Cancers |
|
06/15/09 |
|
Prospect Therapeutics' In Vitro Studies Demonstrate that
GCS-100 Drug Binds to and Blocks the Effects of Galectin-3 |
|
06/05/09 |
|
Ludwig Institute of Cancer Research Ltd., Brussels Branch,
Issues Statement Concerning Prospect Therapeutics Inc's.
GCS-100 Molecule |
|
05/26/09 |
|
Prospect Therapeutics, Inc.'s GCS-100 Inhibited Blood Vessel
Formation in a Variety of Cancer Models |
|
05/19/09 |
|
Prospect Therapeutics, Inc.'s GCS-100 Exhibits a Low
Toxicity Profile in Cancer Patients |
|
05/12/09 |
|
Prospect Therapeutics, Inc. Assigns All Its Assets to Joseph
F. Finn, Jr., C.P.A. for the Benefit of Its Creditors |
|
05/07/09 |
|
Prospect Therapeutics
Assigns Assets to Joseph F. Finn, Jr. C.P.A. for the Benefit
of Creditors |
|
06/01/09 |
|
Interim Phase 2 Results On Prospect Therapeutics' GCS-100
Presented At The 10th International Conference On Malignant
Lymphoma |
| |
|
|
| |
|
|
Source Precision Medicine Inc. D/B/A SourceMDx
|
| |
|
|
|
04/29/2011 |
|
Assets Sold |
|
04/06/2001 |
|
Source Precision Medicine, Inc., d/b/a Source MDx Announces
Source Laboratory Information Management Systems (LIMS),
Source Dynamics and Source Primer/Probe Database Will Be
Offered for Sale on April 29, 2011 |
|
03/29/2011 |
|
Source Precision Medicine, Inc. d/b/a Source MDx Announces
16 Molecular Diagnostic Development Programs Will Be Offered
for Sale on April 29, 2011 |
|
03/21/2011 |
|
Source Precision Medicine, Inc. d/b/a Source MDx Announces
Foundational Patents Will Be Offered for Sale on April 29,
2011 |
|
03/01/11 |
|
Source Precision Medicine, Inc., dba SourceMDx Assigns All
Its Assets to Joseph F. Finn, Jr., C.P.A. of the firm of
Finn, Warnke & Gayton, LLP |
|
02/25/11 |
|
Source Precision Medicine Inc.,
D/B/A Assigns Assets to Joseph F. Finn, Jr. C.P.A. for the
Benefit of Creditors |
| |
|
|
| |
|
|
|
10/10/08
|
|
Assets sold
|
09/15/08
|
|
Spherics, Inc. Announces Reduced Cognitive Impairment of
Novel Extended Release Topiramate (SRx-502) as Compared to
Topamax(R)
|
09/09/08
|
|
Spherics, Inc. Announces Sale of Novel Proprietary
Bioadhesive Polymers and Oral Drug Delivery System
|
09/02/08
|
|
Spherics, Inc. Offers Once Daily Extended Release
Formulation for Sustained and Stable Pramipexole Delivery
|
08/25/08
|
|
Spherics, Inc. Offers Extended Release Formulation for
Sustained and Stable Levodopa Levels
|
08/13/08
|
|
Spherics, Inc. Successful Bidder May Make NDA Submission
|
08/04/08
|
|
Spherics, Inc. Assigns Assets to Joseph F. Finn, Jr., C.P.A.
|